Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECMO for neonatal respiratory failure.

K Rais Bahrami1, Krisa P Van Meurs

  • 1The George Washington University School of Medicine, Department of Neonatology, Children's National Medical Center, 111 Michigan Ave., NW, Washington, DC 20010, USA. KRAISBAH@cnmc.org

Seminars in Perinatology
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Follow-Up of a Randomized Clinical Trial.

JAMA pediatrics·2025
Same author

Early postnatal echocardiographic characteristics impact survival and extracorporeal life support in congenital diaphragmatic hernia.

Pediatric research·2025
Same author

Respiratory Outcomes After Transcatheter vs Surgical Patent Ductus Arteriosus Closure in Preterm Infants.

JAMA network open·2025
Same author

Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial.

JAMA pediatrics·2025
Same author

Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.

JAMA·2025
Same author

Patent Ductus Arteriosus, Hydrocortisone, and Outcome among Infants Born Extremely Preterm: Secondary Analysis of the Hydrocortisone Trial.

The Journal of pediatrics·2025
Same journal

Congenital cytomegalovirus: Screening strategies and diagnostic challenges.

Seminars in perinatology·2026
Same journal

The society for neonatal nutrition and lifelong health: Building science and translating research to inform neonatal nutritional care.

Seminars in perinatology·2026
Same journal

Enteral nutrition to optimize health and neurodevelopmental outcomes in very preterm infants.

Seminars in perinatology·2026
Same journal

Standardizing outcome measures in preterm infant nutrition research: Use of anthropometry and body composition in the neonatal intensive care unit.

Seminars in perinatology·2026
Same journal

A dilemma of parental inclusion? Parent perspectives of NICU feeding practices and neonatal nutritional research.

Seminars in perinatology·2026
Same journal

Maternal diet and nutritional status during pregnancy and lactation: a review of implications on milk composition and lactation outcomes.

Seminars in perinatology·2026
See all related articles

Extracorporeal membrane oxygenation (ECMO) offers a life-saving treatment for newborns with severe respiratory and cardiac failure. This advanced therapy significantly improves survival rates for high-risk neonates facing critical conditions.

Area of Science:

  • Neonatal Medicine
  • Cardiovascular Surgery
  • Pediatric Critical Care

Background:

  • Neonates with severe respiratory and cardiac failure often have poor prognoses.
  • Extracorporeal membrane oxygenation (ECMO) is a critical intervention for neonates unresponsive to conventional treatments.

Purpose of the Study:

  • To review the application of ECMO in neonates with various cardio-respiratory conditions.
  • To discuss ECMO selection criteria, clinical management, and long-term outcomes for neonates.

Main Methods:

  • Review of current literature and clinical practices regarding neonatal ECMO.
  • Analysis of survival rates and diagnostic groups benefiting from ECMO.

Main Results:

  • ECMO demonstrates an 84% overall survival rate in high-risk neonates, contrasting with an 80-85% anticipated mortality.

Related Experiment Videos

  • Recent data indicates near 100% survival in specific diagnostic categories.

    • Conclusions:

    • ECMO is a highly effective life-saving technology for neonates with severe cardio-respiratory failure.
    • Understanding ECMO selection, management, and long-term outcomes is crucial for optimizing neonatal care.